Insider and Institutional Ownership
Institutional investors hold 0.1% of Moolec Science shares, while they hold 33.2% of Thunder Bridge Capital Partners IV shares. Company insiders own 19.9% of Moolec Science compared to 65.1% in Thunder Bridge Capital Partners IV. Strong institutional ownership suggests confidence in long-term growth.
Analyst Ratings
Here are the current ratings for Moolec Science and Thunder Bridge Capital Partners IV:
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Moolec Science | 0 | 0 | 1 | 0 | 3.00 |
| Thunder Bridge Capital Partners IV | 0 | 0 | 0 | 0 | N/A |
Moolec Science has a price target of $6.00, suggesting a potential upside of 552.17%, indicating it is seen more favorably than Thunder Bridge Capital Partners IV.
Profitability
Here’s a comparison of profitability metrics:
| Net Margins | Return on Equity | Return on Assets | |
| Moolec Science | -129.97% | -93.88% | -33.37% |
| Thunder Bridge Capital Partners IV | N/A | -15.04% | -0.48% |
Earnings & Valuation
Comparison of revenue and valuation metrics:
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Moolec Science | $5.63 million | 6.14 | -$7.31 million | ($0.20) | -4.60 |
| Thunder Bridge Capital Partners IV | N/A | N/A | $4.09 million | N/A | N/A |
Thunder Bridge Capital Partners IV has lower revenue but higher earnings than Moolec Science.
Summary
Thunder Bridge Capital Partners IV outperforms Moolec Science in 6 out of 9 comparison factors.
About Moolec Science
Moolec Science SA develops animal proteins from plants using molecular farming. Its products include dairy ingredients, nutritional oil, and meat alternatives, serving markets in the US, Europe, and South America. Founded in 2020, it is based in Luxembourg.
About Thunder Bridge Capital Partners IV
Thunder Bridge Capital Partners IV Inc. focuses on potential mergers and acquisitions. Established in 2021, it is based in Great Falls, Virginia.
Receive News & Ratings for Moolec Science Daily – Enter your email to get daily summaries of the latest news and ratings from MarketBeat.com.
`
